COREY COLLEEN
Known title: EVP, Global Human ResourcesCIK: 0001976271
Associated companies
Transaction History
| BIO | ▲ Buy | Option Exercise | 576 | $0 | 9/6/2025 | View on chart |
| BIO | ▼ Sell | Tax Withholding | 209 | $62K | 9/6/2025 | View on chart |
| BIO | ▲ Buy | Option Exercise | 1,102 | $0 | 9/1/2025 | View on chart |
| BIO | ▼ Sell | Tax Withholding | 398 | $119K | 9/1/2025 | View on chart |
| BIO | ▲ Buy | Option Exercise | 495 | $0 | 9/3/2024 | View on chart |
| BIO | ▼ Sell | Tax Withholding | 177 | $59K | 9/3/2024 | View on chart |
| BIO | ▲ Buy | Option Exercise | 361 | $0 | 9/2/2024 | View on chart |
| BIO | ▼ Sell | Tax Withholding | 129 | $44K | 9/2/2024 | View on chart |
| BIO | ▲ Buy | Option Exercise | 500 | $0 | 9/1/2024 | View on chart |
| BIO | ▼ Sell | Tax Withholding | 179 | $60K | 9/1/2024 | View on chart |
| BIO | ▲ Buy | Option Exercise | 347 | $0 | 9/1/2024 | View on chart |
| BIO | ▼ Sell | Tax Withholding | 124 | $42K | 9/1/2024 | View on chart |
| BIO | ▲ Buy | Option Exercise | 253 | $0 | 9/1/2024 | View on chart |
| BIO | ▼ Sell | Tax Withholding | 91 | $31K | 9/1/2024 | View on chart |
| BIO | ▲ Buy | Option Exercise | 600 | $0 | 9/4/2023 | View on chart |
| BIO | ▼ Sell | Tax Withholding | 208 | $82K | 9/4/2023 | View on chart |
| BIO | ▲ Buy | Option Exercise | 495 | $0 | 9/3/2023 | View on chart |
| BIO | ▼ Sell | Tax Withholding | 172 | $68K | 9/3/2023 | View on chart |
| BIO | ▲ Buy | Option Exercise | 361 | $0 | 9/2/2023 | View on chart |
| BIO | ▼ Sell | Tax Withholding | 125 | $49K | 9/2/2023 | View on chart |
| BIO | ▲ Buy | Option Exercise | 347 | $0 | 9/1/2023 | View on chart |
| BIO | ▼ Sell | Tax Withholding | 120 | $47K | 9/1/2023 | View on chart |
| BIO | ▲ Buy | Option Exercise | 253 | $0 | 9/1/2023 | View on chart |
| BIO | ▼ Sell | Tax Withholding | 88 | $35K | 9/1/2023 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 5, 2026
Bio‑Rad Leads in Recombinant Protein & Magnetic Bead Growth
The latest market report shows the recombinant protein manufacturing sector is expected to triple in revenue by 2030, with Bio‑Rad listed among the key players. A separate analysis projects the magnetic bead market to grow from $3.3 billion in 2025 to $7.4 billion by 2032, again naming Bio‑Rad as a leader. These developments highlight the company’s expanding role in both protein production and diagnostic reagent markets.
Bio‑Rad Leads in Recombinant Protein & Magnetic Bead Growth. The latest market report shows the recombinant protein manufacturing sector is expected to triple in revenue by 2030, with Bio‑Rad listed among the key players. A separate analysis projects the magnetic bead market to grow from $3.3 billion in 2025 to $7.4 billion by 2032, again naming Bio‑Rad as a leader. These developments highlight the company’s expanding role in both protein production and diagnostic reagent markets.